Citrinin (CIT) is a nephrotoxic mycotoxin produced by Penicillium, Monascus, and Aspergillus species. CIT appears as a contaminant in cereals, cereal-based products, fruits, nuts, and spices. During the biotransformation of CIT, its major urinary metabolite dihydrocitrinone (DHC) is formed. Albumin interacts with several compounds (including mycotoxins) affecting their tissue distribution and elimination. CIT-albumin interaction is known; however, the complex formation of DHC with albumin has not been reported previously. In this study, we aimed to investigate the interaction of DHC with albumin, employing fluorescence spectroscopy, circular dichroism, and molecular modeling studies. Furthermore, species differences and thermodynamics of the interaction as well as the effects of albumin on the acute in vitro toxicity of DHC and CIT were also tested. Our main observations/conclusions are as follows: (1) 
Introduction
Citrinin (CIT; Fig. 1 ) is a nephrotoxic mycotoxin produced by filamentous fungi, including Penicillium, Monascus, and Aspergillus genera (de Oliveira Filho et al. 2017 ). CIT appears as a contaminant in cereals, cereal-based products, fruits, nuts, and spices (Bennett and Klich 2003; de Oliveira Filho et al. 2017) . Several CIT-producing fungi are used in food industry during the production of cheese or some Asian foods. Monascus purpureus is applied even nowadays as a natural food colorant, despite the fact that it commonly produces CIT (da Rocha et al. 2014) . The frequent occurrence of CIT in food was likely responsible for the Byellow rice toxins^syndrome/ disease in Japan (1971) (Ciegler and Bennett 1980) . Antibacterial activity of CIT has also been reported because some Gram-positive bacteria are sensitive to CIT; however, it is not used in the pharmacotherapy due to its nephrotoxic effect in humans and animals (de Oliveira Filho et al. 2017) . Based on our current knowledge, the chronic CIT exposure may play a role in the development of endemic nephropathy in pigs and in human (Flajs and Peraica 2009; Peraica et al. 2008) . After oral exposure, CIT is extensively biotransformed in humans, during which its major urinary metabolite dihydrocitrinone (DHC; Fig. 1 ) is formed Huybrechts et al. 2015; Gerding et al. 2015; Degena et al. 2018) . Based on previous reports, DHC appears in a wide concentration range in human blood and urine samples (0.00-1.44 ng/mL and 0.01-2.75 ng/mL, respectively) Huybrechts et al. 2015; Gerding et al. 2015; Ali et al. 2018) . The conversion of CIT to DHC is known as a detoxification reaction, due to the production of the more polar and less toxic metabolite. In vitro cellular toxicity and genotoxicity of DHC is significantly lower compared to the parent compound (Dunn et al. 1983; Föllmann et al. 2014) . Under acidic conditions, CIT expresses strong fluorescence (λ ex = 330 nm; λ em = 505 nm); however, fluorescence signal of CIT strongly decreases with the elevation of the pH and disappears approximately at pH 5, due to the deprotonation of the molecule .
Human serum albumin (HSA) is the most abundant protein in the human circulation. HSA maintains the oncotic pressure of the blood and displays buffering, antioxidant, and pseudoenzymatic activities (Fanali et al. 2012) . HSA forms stable complexes with several endogenous and exogenous compounds (Fanali et al. 2012; Yamasaki et al. 2013) . HSA consists of three domains (I, II, and III), each domain is built up from two subdomains (A and B). The most important binding sites on HSA are Sudlow's site I (subdomain IIA) and Sudlow's site II (subdomain IIIA); however, recent studies draw the attention to the importance of Heme binding site (subdomain IB) (Fanali et al. 2012; Zsila 2013) . The interaction of CIT with HSA and with albumins from other species has been described (Damodaran 1977; Damodaran and Shanmugasundaram 1978; Poór et al. 2015) ; on the other hand, the DHC-albumin complex formation has not been reported. CIT binds to HSA with similar affinity to the oral anticoagulant warfarin (K = 2 × 10 5 L/mol), and its binding site is located in Sudlow's site I (Poór et al. 2015) .
In this study, the complex formation of DHC with albumin was investigated employing fluorescence spectroscopy, circular dichroism, and molecular modeling. Stability of formed DHCalbumin complexes was evaluated based on the fluorescence quenching effect of DHC on albumins. Furthermore, binding constants were also determined, based on the fluorescence enhancement of DHC by albumins. To test the potential species differences, interaction of DHC with human, bovine (BSA), porcine (PSA), and rat (RSA) serum albumins was investigated. To get a deeper insight into the DHC-HSA complex formation, circular dichroism and thermodynamic studies were performed. Binding site of DHC on HSA was evaluated based on modeling studies and experiments with site markers. Finally, to investigate the influence of albumin on the cellular uptake of the mycotoxin, acute toxicity of DHC and CIT was tested in MDCK kidney cell line, in the absence and presence of albumin.
Materials and methods

Reagents
All reagents and solvents were of analytical or spectroscopic grade. The chemical synthesis of (±)-dihydrocitrinone (DHC, MW = 266.25 g/mol) was carried out according to the synthetic procedure for (±)-[ 13 C 3 ]-dihydrocitrinone described by Bergmann et al. (Bergmann et al. 2018) , while (+)-DHC was purchased from AnalytiCon Discovery (Potsdam, Germany). As the natural metabolite (+)-DHC has only limited availability, most studies were performed with synthetic (±)-DHC and only the circular dichroism experiments with (+)-DHC. Citrinin (CIT, MW = 250.25 g/mol), human serum albumin (HSA, MW = 66.4 kDa), bovine serum albumin (BSA, MW = 66.4 kDa), porcine serum albumin (PSA, MW = 67.5 kDa), rat serum albumin (RSA, MW = 64.6 kDa), ochratoxin A (MW = 403.8 g/mol), warfarin (WAR, MW = 308.33), phenylbutazone (MW = 308.37 g/mol), furosemide (MW = 330.74 g/mol), ibuprofen (MW = 206.28 g/mol), methyl orange (MW = 327.34 g/mol), bilirubin (MW = 584.66 g/mol), zearalenone (MW = 318.36 g/mol), Lthyroxine (MW = 776.87 g/mol), and Dulbecco's modified Eagle medium (DMEM) were purchased from SigmaAldrich. Fetal bovine serum (FBS, from Pan-Biotech) and Bioluminescent ATP Assay Kit CLSII (from Roche) were used as received.
, and L-thyroxine (2500 μmol/L) were prepared in 96 v/v% ethanol (Renal, spectroscopic grade); while methyl orange (2000 μmol/L) and bilirubin (500 μmol/L) were dissolved in dimethyl sulfoxide (Fluka, spectroscopic grade). Stock solutions were stored at − 20°C protected from light. To mimic extracellular physiological conditions, measurements were carried out in phosphate-buffered saline (PBS: 8.00 g/L NaCl, 0.20 g/L KCl, 1.81 g/L Na 2 HPO 4 × 2H 2 O, 0.24 g/L KH 2 PO 4 ; pH 7.4). 
Spectroscopic measurements
Steady-state fluorescent spectroscopic and fluorescence anisotropy measurements were carried out employing a Hitachi F-4500 fluorescence spectrophotometer (Tokyo, Japan). Analyses were performed at 25°C (except thermodynamic studies) in the presence of air. In order to exclude the inner filter effect, UV-Vis spectra of DHC, CIT, warfarin, phenylbutazone, furosemide, ibuprofen, methyl orange, bilirubin, zearalenone, and L-thyroxine were also recorded, applying a Specord Plus 210 (Analytic Jena AG, Jena, Germany) spectrophotometer. Fluorescence emission intensities were corrected with the following equation (Hu and Liu 2015) :
where I cor and I obs denote the corrected and observed fluorescence emission intensities, respectively; while A ex and A em are the absorbance values of compounds (DHC, CIT, ibuprofen, warfarin, phenylbutazone, furosemide, methyl orange, bilirubin, zearalenone, L-thyroxine) at the excitation and emission wavelengths used, respectively. During fluorescence quenching studies, increasing concentrations of DHC (0.0, 0.5, 1.0, 2.0, 3.0, and 4.0 μmol/L; 0.00-1.07 mg/L range) were added to standard amount of albumin (2 μmol/L) in PBS (pH 7.4). Quenching experiments were evaluated based on the Stern-Volmer equation (Hu and Liu 2015) :
where I 0 and I are fluorescence intensities of albumin without and with DHC, respectively (λ ex = 295 nm, λ em = 340 nm), K SV is the Stern-Volmer quenching constant (unit L/mol), while [Q] is the concentration of the quencher (unit mol/L). Binding constants (K) of DHC-albumin complexes were determined by non-linear fitting, using the Hyperquad2006 program package (Protonic Software), during which the following equations were implemented in the Hyperquad code (SA, serum albumin) :
where p and q indicate the stoichiometry of the equilibrium in the solution. In Hyperquad2006 computer fitting program, all equilibrium constants were defined as overall binding constants (see below).
The relationship between the overall binding constants and the stepwise binding constants were calculated by the Hyperquad based on the following:
The stoichiometry and binding constant of DHC-albumin complexes were determined using the model associated with the lowest standard deviation.
Fluorescence spectra of DHC and DHC-albumin complexes were recorded applying 325 and 405 nm as excitation and emission wavelengths, respectively. Increasing albumin concentrations (0, 0.5, 1.0, 1.5, 2.0, 3.0, 4.0, 5.0, 6.0, 8.0, 10.0, 12.5, and 15 .0 μmol/L) were added to standard amount of DHC (2 μmol/L, 0.533 mg/L) in PBS (pH 7.4). Binding constants were determined by the Hyperquad2006 software (see Eqs. 3-7).
To investigate the displacement of DHC from HSA by site markers, increasing concentrations of ibuprofen, phenylbutazone, furosemide, methyl orange, bilirubin, zearalenone, and L-thyroxine (0, 1, 2, 4, and 6 μmol/L each) were added to standard amount of DHC and HSA (2 and 4 μmol/L, respectively). Fluorescence emission spectra were recorded in PBS (pH 7.4) using the wavelength maximum of DHC-albumin complexes (λ ex = 325 nm, λ em = 405 nm). Since the complex formation of DHC with albumin results in significant enhancement of the fluorescence of the mycotoxin metabolite, displacement of DHC from HSA leads to the significant decrease of its fluorescence signal.
Thereafter, the influence of DHC (vs. CIT and warfarin) on the fluorescence anisotropy of ochratoxin A-HSA complex was examined using the previously described method (Poór et al. 2015) . Increasing concentrations of DHC, CIT, and warfarin (0-30 μmol/L each) were added to standard amounts of ochratoxin A and HSA (1 μmol/L and 1.5 μmol/L, respectively) in PBS (pH 7.4). Then, fluorescence anisotropy values of these samples were determined using 394 and 447 nm as excitation and emission wavelengths, respectively (wavelength maxima of albumin-bound ochratoxin A). Fluorescence anisotropy (r) data were calculated employing the following equation (Lakowicz 2006) :
where G is the instrumental factor and I VV and I VH are emission intensities measured in vertical position of polarizer at pre-sample site, and at vertical and horizontal position of post-sample polarizer, respectively.
Circular dichroism
The circular dichroism spectra of (+)-DHC were measured at room temperature using a 1-cm cell with a Jasco J-600 CD spectrometer (Jasco, Groß-Umstadt, Germany). The spectra were recorded between 200 and 270 nm with 1 nm step size, 1 nm bandwidth, 100 nm/min speed and an average time of 0.5 s. Five measurements from each sample were performed and averaged without using the smoothing function. Two different DHC concentrations ( Ellipticity (θ MRE ) was used for converting the observed ellipticity (θ obs ) to the mean residue based on the following equation:
where C p is the protein concentration (4.8 × 10 −7 mol/L), n is the number of amino acids of HSA (584) and l is the length of the cuvette (1 cm). For the calculation of the α-helix percentage, the following equation was employed, and software K2D3 was utilized (Wang et al. 2013; Ajmal et al. 2017; Louis-Jeune et al. 2012) .
For the K2D3 software, the θ MRE from 200 to 240 nm and the protein size of 584 amino acids were applied.
Thermodynamic studies
To get a deeper insight into the DHC-HSA interaction, thermodynamic parameters were determined, during which binding constants of complexes were calculated at six different temperatures (298, 301, 304, 307, 310, and 313 K) . Binding constants (K) were quantified based on fluorescence spectroscopic measurements employing the Hyperquad2006 software (see Eqs. 3-7), using 325 and 405 nm excitation and emission wavelengths, respectively. Thermodynamic parameters associated to the complex formations between DHC and HSA were determined using the van't Hoff equation:
where ΔG, ΔH, and ΔS reflect the Gibbs free energy, enthalpy, and entropy changes of the binding reaction, respectively; while R refers to the gas constant and T is the temperature.
Modeling studies
The ligand structure was built in Maestro (Schrödinger 2017) . The raw structure was energy minimized, using the semiempirical quantum chemistry program package, MOPAC and the PM6 parameterization (Stewart 2007). The gradient norm was set to 0.001. The energy minimized structure was subjected to force calculations. The force constant matrices were positive definite. The minimized ligand structures were then used in our docking calculations. An apo crystallographic structure (PDB code: 1ao6) of HSA was used as target molecule in our calculations. Acetyl and amide capping groups were attached to the N-and Ctermini, respectively, using the Schrödinger Maestro program package v. 9.6 (Schrödinger 2017). As 1ao6 contains a homodimer structure, only chain A was used for calculations. Cocrystallized ions and water molecules were removed before minimizing the protein structure. The target molecule was minimized using a two-step protocol with the GROMACS software package (Abraham et al. 2015) , including a steepest descent and a conjugate gradient step, and using AMBER99-ildn force field (Lindorff-Larsen et al. 2010) . Exit tolerance levels were set to 1000 and 10 kJ mol −1 nm −1 while maximum step sizes were set to 0.5 and 0.05 nm, respectively. The minimized target was then used in our docking calculations. Using the optimized ligand and target structures, blind docking calculations were performed with AutoDock 4.2 program package (Morris et al. 2009 ) as described in our previous publications (Poór et al. 2015; Hetényi and van der Spoel 2002 , 2006 , 2011 . Gasteiger-Marsilli partial charges were added to both the ligand and target atoms, using AutoDock Tools (Morris et al. 2009 ) and united atom representation was applied for non-polar moieties. A grid box of 250 × 250 × 250 points and 0.375 Å spacing was calculated and centered on target center of mass by AutoGrid 4. Lamarckian genetic algorithm was used for global search. Flexibility was allowed on the ligand at all active torsions, number of docking runs was set to 100, and numbers of energy evaluations and generations were 20 million (Hetényi and van der Spoel 2006) . Ligand conformations that resulted from the docking runs were ordered by the corresponding calculated interaction energy values and subsequently clustered using a tolerance of 1.75 Å root mean square deviation (RMSD) between cluster members (Hetényi and van der Spoel 2002) .
Cell cultures and ATP-based cell viability assay MDCK (Madin-Darby canine kidney epithelial cells, ATCC, CCL-34) adhesion cell line was cultured in DMEM supplemented with 10% FBS, penicillin (100 U/mL), and streptomycin (100 μg/mL), in a humidified atmosphere (5% CO 2 ) at 37°C. Trypsinized cells were plated in 96-well plastic plates (approximately 10 4 cells/well). Before the treatment, the culture medium was replaced with fresh one (without FBS/ HSA, with FBS, or with HSA), then cells were incubated with 50 μmol/L (DHC 13.313 mg/L; CIT 12.513 mg/L) or 100 μmol/L (DHC 26.625 mg/L; CIT 25.025 mg/L) mycotoxin concentrations in the absence and in the presence of 10% FBS or 40 g/L HSA. After 24-h incubation, ATP levels were quantified applying the previously described method without any modifications (Sali et al. 2016) .
Statistics
Means and standard error (± SEM) values were expressed in figures. Statistical evaluation of experiments with site markers and in vitro cell experiments were carried out using one-way ANOVA test (IBM SPSS Statistics, Version 21), during which the level of significance was set at p < 0.05 and p < 0.01.
Results and discussion
Fluorescence spectroscopic investigation of DHC in the absence and presence of HSA First, the fluorescence excitation and emission spectra of DHC were recorded in PBS (pH 7.4). Despite the parent compound (CIT) does not express fluorescence at physiological pH , conversion of CIT to DHC leads to significant spectral changes. As Fig. S1 demonstrates, DHC showed fluorescence property in PBS, exerting its excitation and emission wavelength maxima at 325 and 420 nm, respectively. Because interaction of fluorophores with albumin can lead to changes in their fluorescence (Sueck et al. 2018) , the influence of HSA on the fluorescence emission spectrum of DHC was tested. Increasing amounts of HSA (final concentrations 0-15 μmol/L) were added to DHC (2 μmol/L) in PBS, then emission spectra were recorded (λ ex = 325 nm). In a dose-dependent fashion, HSA caused a significant fluorescence enhancement of DHC, during which the blue shift of the emission wavelength maximum of DHC (420 → 405 nm) was noticed (Fig. 2a) . Under the applied conditions, HSA also shows some fluorescence emission; however, the increase in fluorescence resulted from the presence of HSA is relatively low (Fig. 2b) . Considering the highest molecular orbital of DHC, the aromatic moiety takes part in the fluorescence process through two ways: (a) the interaction of the aromatic ring in DHC with the surface of albumin modifies the fluorescence efficiency of the aromatic moiety; (b) the partial removal of water molecules from the solvation shell of DHC, prior its interaction with the albumin, enhances the fluorescence of DHC due to the reduced number of the quencher water molecules in the solvation shell. These observations strongly suggest the formation of DHC-HSA complexes. Since the increased fluorescence at 405 nm is partly originating from the fluorescence signal of HSA, emission intensities were corrected during the calculation of binding constants (see later in the BBinding constants of DHC-albumin complexes^section).
Fluorescence quenching of HSA by DHC
Fluorescence emission spectrum of HSA (2 μmol/L) was recorded in PBS (pH 7.4), in the absence and presence of increasing concentrations of DHC (0-4 μmol/L; λ ex = 295 nm, λ em = 340 nm). Using 295 nm as excitation wavelength, HSA shows emission maximum at 340 nm, while a second peak at higher wavelength (approximately at 405 nm) also appears in the presence of DHC, due to the fluorescence emission of DHC and DHC-HSA complex (Fig. 3a) . In a concentrationdependent fashion, DHC induced the decrease of the fluorescence signal at 340 nm as a result of the fluorescence quenching effect of DHC on HSA. To exclude the inner filter effect, fluorescence signal of HSA was corrected based on Eq. 1. The good linearity of the Stern-Volmer plot (R 2 = 0.993) recommends 1:1 stoichiometry of complex formation. The decrease in the slope of the Stern-Volmer plot at higher temperature values suggests the static quenching process of HSA by DHC (see below in the BThermodynamics of DHC-HSA complex formation^section).
Binding constants of DHC-albumin complexes
In order to evaluate the stability of DHC-albumin complexes and the potential species differences of DHC-albumin interactions, experiments described in the previous two sections were performed with bovine, porcine, and rat serum albumins. Similarly to HSA, other albumins also induced the significant fluorescence enhancement of DHC (Fig. S2) . The strongest enhancers were HSA and RSA causing approximately 75-fold increase in the fluorescence of DHC, while the less effective enhancers BSA and PSA led to the 60-fold and 25-fold elevation of fluorescence, respectively. Fluorescence quenching effect of DHC was the highest in the presence of RSA, followed by HSA and BSA, while the lowest decrease of fluorescence was observed with PSA ( Fig. 3b) .
Quantitation of binding constants was determined using both models: (a) enhancement of the fluorescence of DHC by albumins (Fig. S2 ) and (b) quenching the fluorescence of albumins by DHC (Fig. 3) . Decimal logarithmic values of Stern-Volmer quenching constants (K SV ; unit L/mol) and binding constants (K; unit L/mol) are demonstrated in Table 1 for each examined DHC-albumin complexes. The logK SV values determined based on the Stern-Volmer equation (Eq. 2) were in a good correlation with the logK values calculated using the Hyperquad program (Eqs. 3-7). The quenching model suggests somewhat lower binding constants compared to the other approach; however, the tendencies of species differences are similar in both models. DHC forms the most stable complex with RSA, followed by HSA, BSA, and PSA. The stability of DHC-RSA complex is approximately 4-5 times higher compared to DHC-PSA; however, only moderate species differences were observed during the comparison of the binding constant of DHC-HSA with other DHCalbumin complexes. Albumin-binding of some mycotoxins shows large species-dependent differences, for example ochratoxin A and zearalenone/zearalenols . From this point of view, DHC behaves very similarly to the parent compound CIT; the latter binds to HSA with almost the same affinity (logK = 5.32) and shows similar species differences to DHC (Poór et al. 2015) .
Circular dichroism of HSA with DHC
Circular dichroism (CD) is a useful analytical tool for the characterization of the secondary structure of proteins as the absorption of the circularly polarized light between 200 and 240 nm provides information on the percentage of α-helices and β-sheets of a protein (Wang et al. 2013) . Based on the limited availability of the natural isomer (+)-DHC, it was examined only in CD experiments (other studies were performed with (±)-DHC). In order to recognize changes in the secondary structure of HSA in the presence of (+)-DHC, CD spectra of the single compounds and their mixture were recorded in the 200-270 nm range. For the CD experiments, a 0.48 μmol/L concentration of HSA in 30 mmol/L phosphate buffer (pH 7.4) was used and for the incubation of HSA with (+)-DHC at equimolar concentration. While (+)-DHC did not show a CD effect, characteristic CD spectra for HSA and the mixture of HSA and (+)-DHC were recorded (Fig. 4) .
The mean residue ellipticity (θ MRE ) of the native HSA at the characteristic wavelength minima of 208 nm and 222 nm indicate that the native protein had predominantly α-helix secondary structure (Fig. 4) . The characteristic minima that are indicative for the α-helices are caused by amino acids of the protein (Wang et al. 2013 ). In the presence of DHC, a DHC dihydrocitrinone, HSA human serum albumin, BSA bovine serum albumin, PSA porcine serum albumin, RSA rat serum albumin slight increase of θ MRE was observed at these characteristic wavelengths of 208 nm and 222 nm. These observations suggest that the complex formation of DHC with HSA leads to a slight change in the secondary structure of HSA, resulting in a decrease of α-helicity (Fig. 4) . The native HSA had α-helix percentage of 67.4 to 73.3% (Table 2 ). After incubation with DHC, the α-helicity of HSA was reduced by 3-9%, suggesting the formation of DHC-HSA complexes. HSA (0.48 μmol/L) was also incubated with double equivalent concentration of DHC (0.98 μmol/L) under the same conditions, during which no further increase of the θ MRE was observed.
Thermodynamics of DHC-HSA complex formation
The temperature dependence of the binding constants of DHC-HSA complex was investigated between 298 and 313 K. Similarly to the CIT-HSA complex (Poór et al. 2015) , the logK values of DHC-HSA show higher stability at lower temperatures, reflecting the presence of ground state complexes. Fig. S3 demonstrates the van't Hoff plot of DHC-HSA complex, and the thermodynamic parameters derived from the slope and the intercept of the line fitted to the logK values (Eq. 11). ΔH and ΔS associated to the DHC-HSA complex formation were found to be − 22.65 kJ mol ) (Poór et al. 2015) . Thermodynamic data indicate similar binding characteristics of DHC-HSA and CIT-HSA complexes, namely electrostatic forces play a major role in the complex formation. According to the entropy gain of DHC-HSA interaction, it is reasonable to hypothesize the partial decomposition of the solvation shells of interacting molecules, leading to a less ordered structure of water molecules (Ross and Subramanian 1981) .
Modeling studies
Blind docking calculations resulted in 100 ligand conformations, which were further clustered as described in the BMaterials and methods^section. After clustering, five ligand conformations were obtained, which were ordered by the calculated interaction energy between the target and the ligand molecule. Out of the five clusters, the first four are illustrated in Fig. 5a , and discussed in the following.
Each analyzed docking rank bound to known binding pockets (Fanali et al. 2012 ). The first rank (rank 1) bound to the Sudlow's site I (binding site of the oral anticoagulant warfarin; Fig. S4a ), the second rank (rank 2) partially occupied the FA9 binding site (near to one of the binding sites of Lthyroxine; Fig. S4b ), the third rank (rank 3) bound to approximately 10 Å distance from the binding site of mycotoxin zearalenone (Fig. S4c) , and the fourth rank (rank 4) bound to the Heme binding site (FA1; one of its typical ligands is bilirubin; Fig. S4d) .
The binding conformation of rank 4 DHC interacts with both hydrophobic (L115, I142) and hydrophilic (R114, H146, R145, R186, K190) amino acids in the Heme binding site (Fig. 5b) . The DHC is secured in the Heme site through Hbonds and salt bridges between the hydrophilic amino acids and the carboxyl and hydroxyl groups of the DHC. The hydrophobic interactions act between L115 and I142 amino acids and the methyl groups of the DHC.
Investigation of the binding site of DHC on HSA using site markers
To examine the binding site of DHC on HSA, some typical ligands of Sudlow's site I (phenylbutazone and furosemide), Sudlow's site II (ibuprofen), and Heme binding site (bilirubin and methyl orange) were applied (Fanali et al. 2012; Zsila 2013). Furthermore, to test the potential involvement of rank 2 (FA9) or rank 3 as binding sites, the effects of L-thyroxine and zearalenone on DHC-HSA interaction were also tested. In these experiments, our previous observation that albuminbinding significantly increases the fluorescence signal of DHC was utilized (Fig. 2) . Using this principle, it is reasonable to hypothesize that the displacement of DHC from albumin leads to the significant decrease in its fluorescence at 405 nm (emission wavelength maximum of HSA-bound DHC). Therefore, fluorescence emission spectrum of DHC-HSA complex (2 and 4 μmol/L, respectively) was recorded in the presence of increasing concentrations of site markers (0, 1, 2, 4, and 6 μmol/L) in PBS (λ ex = 325 nm). The concentrations of solvents did not exceed 1.2 v/v% which did not influence the fluorescence of DHC-HSA complex in the absence of site markers. As Fig. 6a demonstrates, the presence of Lthyroxine and zearalenone and the markers of Sudlow's site I and II induced negligible changes in the fluorescence of DHC-HSA complex. On the other hand, both markers of the Heme binding site (methyl orange and bilirubin) significantly decreased the fluorescence at 405 nm, suggesting the displacement of DHC from HSA by these compounds, and the involvement of the Heme binding site regarding DHC-HSA interaction. The binding constant of bilirubin-HSA complex is much higher compared to methyl orange-HSA (Ahlfors 1981; Zsila 2013) , which is in agreement with our observation that bilirubin can induce stronger displacement of DHC from HSA compared to methyl orange.
Previous investigations revealed that CIT occupies Sudlow's site I as its primary binding site on HSA (Poór et al. 2015) . Since the binding constant, the binding mode, and species differences of DHC-albumin complex are very similar to the CIT-albumin complex, it is surprising that DHC occupies another binding site than CIT. Thus, to confirm these results, further experiments were performed with the known markers of site I, namely warfarin and ochratoxin A (Il'ichev et al. 2002) . During this experiment, our previously described model was employed (Poór et al. 2015) . Since ochratoxin A is a small fluorophore, its interaction with the macromolecule (HSA) results in the significant decrease in its rotational freedom and consequently the strong increase of fluorescence polarization or anisotropy values of the mycotoxin. Based on these principles, albumin-binding of ochratoxin A can be precisely followed by fluorescence polarization or anisotropy techniques (Poór et al. 2015) . Fluorescence anisotropy of ochratoxin A with HSA (1.0 and 1.5 μmol/L, respectively) was determined in the presence of increasing concentrations of DHC, CIT, or warfarin (each 0, 1, 5, 10, 20, and 30 μmol/L). CIT and warfarin induced similar (but statistically not significant) decrease in the fluorescence anisotropy of ochratoxin A, while DHC caused only a slight effect (Fig. 6b) . Since the decrease in fluorescence anisotropy is resulted from the increased rotational freedom of ochratoxin A, this observation suggests the displacement of ochratoxin A from HSA in the presence of CIT and warfarin. The fact that even relatively large concentrations of DHC failed to significantly decrease the anisotropy value of ochratoxin A supports our previous finding that the binding site of DHC is not located in Sudlow's site I.
Influence of albumin on the acute cellular toxicity of DHC and CIT In order to examine the influence of albumin on the acute cellular toxicity of DHC and CIT, MDCK kidney cells were treated with these mycotoxins in the absence and presence of 10% FBS or 40 g/L HSA. Cell culture media usually contains 10% FBS (final concentration of BSA approximately 3.5 g/L), while 40 g/L is a typical HSA concentration in the human blood. Since the acute cytotoxicity of DHC and CIT is relatively low, high mycotoxin concentrations (50 and 100 μmol/L) were applied to produce remarkable toxic effects. Each sample (including the control) contained the same ethanol concentrations (4 v/v%, which was the solvent of CIT and DHC). Mycotoxin-induced loss of cell viability was evaluated based on ATP levels/well after 24-h incubation. As Fig. 7 demonstrates, the applied mycotoxin concentrations caused significant decrease of ATP. In agreement with previous studies, the lower toxicity of DHC was observed compared to CIT (Föllmann et al. 2014 ). In the presence of FBS and HSA, the cytotoxicity of both CIT and DHC significantly decreased (Fig. 7) , most likely due to the formation of stable mycotoxin-albumin complexes which can limit the cellular uptake of these mycotoxins. Stronger effect of HSA (vs. FBS) can be mainly attributed to the lower BSA concentration in the cell medium (3.5 g/L BSA vs. 40 g/L HSA). Therefore, our results demonstrate that the interaction of DHC with albumin may significantly affect the tissue uptake of the mycotoxin.
In conclusion, the interaction of DHC with albumin was investigated by fluorescence spectroscopy, circular dichroism, and molecular modeling. Binding constant and binding site, speciesdependent alternations, and thermodynamics of the interaction were characterized, as well as the effects of albumin on the in vitro cytotoxicity of DHC and CIT were also tested. DHC exerts fluorescence signal at physiological conditions, which is strongly enhanced by albumin. Besides the increased fluorescence of DHC in the presence of albumins, the formation of DHC-albumin complexes is also supported by fluorescence quenching and circular dichroism studies. Stability of DHC-HSA, DHC-BSA, and DHC-PSA complexes were similar, while DHC binds to RSA with slightly higher affinity compared to other albumins tested. Binding constant of DHC-HSA complex is similar to CIT-HSA; however, DHC occupies Heme binding site (FA1; subdomain IB) on HSA while CIT is a ligand of Sudlow's Site I (subdomain IIA). Thermodynamic studies suggest the spontaneous binding process between DHC and HSA at room temperature, during which electrostatic forces play a major role. Furthermore, the partial decomposition of the solvation shells can be assumed. Albumin decreased significantly the toxic effects of both DHC and CIT on MDCK cells, which also confirms the formation of stable mycotoxin-albumin complexes. 
